BACKGROUND: Breast and ovarian cancers are the most prevalent cancers and one of the leading causes of death in Indian women. The healthcare burden of breast and ovarian cancers and the rise in mortality rate are worrying and stress the need for early detection and treatment. METHODS: We performed amplicon sequencing of 144 cases who had breast/ovarian cancer disease (total 137 cases are patients and seven are tested for BRCA1/2 carrier) Using our custom designed gene panel consisting of 14 genes, that are associated with high to moderate risk of breast and ovarian cancers. Variants were called using Torrent Variant Caller and were annotated using ThermoFisher's Ion Reporter software. Classification of variants and their clinical significance were identified by searching the variants against ClinVar database. RESULTS: From a total of 144 cases, we were able to detect 42 pathogenic mutations in [40/144] cases. Majority of pathogenic mutations (30/41) were detected in BRCA1 gene, while (7/41) pathogenic mutations were detected in BRCA2 gene, whereas, (2/41) pathogenic mutations were detected in TP53 gene and BRIP1, PALB2, and ATM genes respectively. So, BRCA genes contributed 88.09% of pathogenic mutations, whereas non-BRCA genes contributed 11.91% of pathogenic mutations. We were also able to detect 25 VUS which were predicted to be damaging by in silico prediction tools. CONCLUSION: Early detection of cancers in the Indian population can be done by genetic screening using customized multi-gene panels. Indications of our findings show that in the Indian population, apart from the common BRCA genes, there are other genes that are also responsible for the disease. High frequency mutations detected in the study and variants of uncertain significance predicted to be damaging by in silico pathogenicity prediction tools can be potential biomarkers of hereditary breast and ovarian cancer in Indian HBOC patients.
BACKGROUND: Breast and ovarian cancers are the most prevalent cancers and one of the leading causes of death in Indian women. The healthcare burden of breast and ovarian cancers and the rise in mortality rate are worrying and stress the need for early detection and treatment. METHODS: We performed amplicon sequencing of 144 cases who had breast/ovarian cancer disease (total 137 cases are patients and seven are tested for BRCA1/2 carrier) Using our custom designed gene panel consisting of 14 genes, that are associated with high to moderate risk of breast and ovarian cancers. Variants were called using Torrent Variant Caller and were annotated using ThermoFisher's Ion Reporter software. Classification of variants and their clinical significance were identified by searching the variants against ClinVar database. RESULTS: From a total of 144 cases, we were able to detect 42 pathogenic mutations in [40/144] cases. Majority of pathogenic mutations (30/41) were detected in BRCA1 gene, while (7/41) pathogenic mutations were detected in BRCA2 gene, whereas, (2/41) pathogenic mutations were detected in TP53 gene and BRIP1, PALB2, and ATM genes respectively. So, BRCA genes contributed 88.09% of pathogenic mutations, whereas non-BRCA genes contributed 11.91% of pathogenic mutations. We were also able to detect 25 VUS which were predicted to be damaging by in silico prediction tools. CONCLUSION: Early detection of cancers in the Indian population can be done by genetic screening using customized multi-gene panels. Indications of our findings show that in the Indian population, apart from the common BRCA genes, there are other genes that are also responsible for the disease. High frequency mutations detected in the study and variants of uncertain significance predicted to be damaging by in silico pathogenicity prediction tools can be potential biomarkers of hereditary breast and ovarian cancer in Indian HBOC patients.
Authors: Andrea Desmond; Allison W Kurian; Michele Gabree; Meredith A Mills; Michael J Anderson; Yuya Kobayashi; Nora Horick; Shan Yang; Kristen M Shannon; Nadine Tung; James M Ford; Stephen E Lincoln; Leif W Ellisen Journal: JAMA Oncol Date: 2015-10 Impact factor: 31.777
Authors: R B Bar-Sade; A Kruglikova; B Modan; E Gak; G Hirsh-Yechezkel; L Theodor; I Novikov; R Gershoni-Baruch; S Risel; M Z Papa; G Ben-Baruch; E Friedman Journal: Hum Mol Genet Date: 1998-05 Impact factor: 6.150
Authors: Stephen E Lincoln; Yuya Kobayashi; Michael J Anderson; Shan Yang; Andrea J Desmond; Meredith A Mills; Geoffrey B Nilsen; Kevin B Jacobs; Federico A Monzon; Allison W Kurian; James M Ford; Leif W Ellisen Journal: J Mol Diagn Date: 2015-07-22 Impact factor: 5.568
Authors: Jun Li; Huong Meeks; Bing-Jian Feng; Sue Healey; Heather Thorne; Igor Makunin; Jonathan Ellis; Ian Campbell; Melissa Southey; Gillian Mitchell; David Clouston; Judy Kirk; David Goldgar; Georgia Chenevix-Trench Journal: J Med Genet Date: 2015-11-03 Impact factor: 6.318
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur Journal: Nature Date: 2020-05-27 Impact factor: 69.504
Authors: Van Thuan Tran; Sao Trung Nguyen; Xuan Dung Pham; Thanh Hai Phan; Van Chu Nguyen; Huu Thinh Nguyen; Huu Phuc Nguyen; Phuong Thao Thi Doan; Tuan Anh Le; Bao Toan Nguyen; Thanh Xuan Jasmine; Duy Sinh Nguyen; Hong-Dang Luu Nguyen; Ngoc Mai Nguyen; Duy Xuan Do; Vu Uyen Tran; Hue Hanh Thi Nguyen; Minh Phong Le; Yen Nhi Nguyen; Thanh Thuy Thi Do; Dinh Kiet Truong; Hung Sang Tang; Minh-Duy Phan; Hoai-Nghia Nguyen; Hoa Giang; Lan N Tu Journal: Front Oncol Date: 2022-01-05 Impact factor: 6.244